Withering
DOI:
https://doi.org/10.36399/5x346a66Keywords:
Motor Neuron Disease, ALSReferences
Blasco, H., Mavel, S., Corcia, P. and Gordon, P.H. (2014). The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development. Current Medicinal Chemistry, 21(31), 3551–3575. doi:https://doi.org/10.2174/0929867321666140916120118.
Feldman, E.L., Goutman, S.A., Petri, S., Mazzini, L., Savelieff, M.G., Shaw, P.J. and Sobue, G. (2022). Amyotrophic lateral sclerosis. The Lancet [online], 400(10360), 1363–1380. doi:https://doi.org/10.1016/S0140-6736(22)01272-7.
Grad, L.I., Rouleau, G.A., Ravits, J. and Cashman, N.R. (2017). Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harbor perspectives in medicine [online], 7(8), p.a024117. doi:https://doi.org/10.1101/cshperspect.a024117.
Mayo Clinic (2019). Amyotrophic Lateral Sclerosis (ALS) [online], Mayo Clinic. Available at: https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/symptoms-causes/syc-20354022.
McCarty, E.B. and Chao, T.N. (2021). Dysphagia and Swallowing Disorders. Medical Clinics of North America, 105(5), pp.939–954. doi:https://doi.org/10.1016/j.mcna.2021.05.013.
The ALS Association. (2024). Disease Mechanisms. [online] Available at: https://www.als.org/research/als-research-topics/disease-mechanisms.
